There are companies in Canada, like NeuVax or Therapure that have biological molecule production facilities.
For the cell culture vaccines, which are Johnson & Johnson and AstraZeneca, it's just a question of having cell culture capacity.
If we can't do that in Canada, it is the industry norm to do that with contractors. We could simply hire one of the contractors, like Emergent, Lonza or Fujifilm, and ask them to lay on another batch. That would be a very simple negotiation.
The lawyer in me feels that, with the company that is the patent holder, you would essentially be asking them just to expand their contract manufacturing with an established contractor. We pay the freight, and we take the risk on the production, so why not?